Mantle Cell Lymphoma

Featured

Quiz
Quiz: Impact of Comorbidities on Treatment Choices for Older Patients With MCL
True or False: Older patients with MCL have a high rate of comorbidities impacting treatment choices and OS.
Quiz
Quiz: Is KTE-X19 a Cost-Effective Treatment for MCL?
True or False: KTE-X19 is a cost-effective alternative to the current standard of care for relapsed/refractory MCL.
News
Cost-Effectiveness of KTE-X19 vs Standard of Care for Relapsed/Refractory MCL
KTE-X19 is a potentially cost-effective alternative to the current standard of care for relapsed/refractory MCL.
Quiz
Quiz: MRD Status for Patients With MCL
True or False: Positive MRD status after induction and consolidation treatments for patients with MCL is associated…
Quiz
Quiz: Is Pre-Transplant MRD Status Predictive of Survival in MCL?
True or False: MRD status prior to autologous stem cell transplantation is an early predictor of PFS and OS in younger…

News

Cost-Effectiveness of KTE-X19 vs Standard of Care for Relapsed/Refractory MCL
Real-World Practice Patterns, Comorbidities in Medicare Patients With MCL
MRD Linked to Worse Survival Outcomes in Patients With MCL
Treatment Patterns and Outcomes Among US Patients With MCL Treated With Ibrutinib

Podcast

Novel BTK Inhibitor Promising for Mantle Cell Lymphoma

Conference Coverage

Clinical and Economic Burden of MCL in the VHA Population
Back to Top